Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
These companies are in the early days of their growth stories.
Stay updated with breaking news from Crispr Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These companies are in the early days of their growth stories.
These risky stocks can deliver big returns for investors.
Wider availability of cheaper CAR-T cell therapy or engineering immune cells to treat blood cancer and a government HPV vaccination programme will be among the key breakthroughs
The FDA has approved the world’s first gene-edited treatment for symptoms of sickle cell disease. Experts weigh in on the potential benefits and limitations.
The Food and Drug Administration (FDA) on Friday approved a new therapy for treating sickle cell disease, marking the first instance of CRISPR gene editing receiving approval from federal regulators. The FDA approved on Friday two new treatments for sickle cell disease (SCD): Casgevy and Lyfgenia. Casgevy, also known as exa-cel, is developed through a…